S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults
Completed · Phase 3 · Has a placebo group
Conditions studied: Pain
In brief
Lasers are used for non-ablative resurfacing of facial rhytides, atrophic scars, and a variety of epidermal and dermal lesions. Pain associated with the non-ablative laser treatment has been described as moderate to severe. For this reason, local anesthesia is commonly used to eliminate or minimize the pain. S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a eutectic formulation of lidocaine and tetracaine. The purpose of this study is to evaluate if S-Caine Peel is effective in providing topical local dermal anesthesia for non-ablative facial laser resurfacing in adults.
Key facts
- Study ID
- NCT00110747
- Run by
- ZARS Pharma Inc.
- People needed
- 54
- Starts
- 2005-06-01
- Expected to finish
- 2005-09-01
- Last updated by the study team
- 2012-06-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient is 18 years of age or older
- Patient elects to undergo non-ablative facial laser resurfacing procedure
You may not qualify if…
- Patient is pregnant or breastfeeding
- Patient has participated in a clinical trial of an unapproved drug within the previous 30 days
- Patient has participated in any previous clinical trial involving S-Caine Peel
Where it is running
- Midwest Cutaneous Research — Clinton Township, Michigan, United States
- Laser and Skin Surgery Center of New York — New York, New York, United States
- New York Dermatology — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.